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Multiple transcription factors have been shown to promote pancreatic β-cell differentiation, yet much less is known
about negative regulators. Earlier epigenomic studies suggested that the transcriptional repressor REST could be a
suppressor of endocrinogenesis in the embryonic pancreas. However, pancreatic Rest knockout mice failed to show
abnormal numbers of endocrine cells, suggesting that REST is not a major regulator of endocrine differentiation.
Using a different conditional allele that enables profound REST inactivation, we observed a marked increase in
pancreatic endocrine cell formation. REST inhibition also promoted endocrinogenesis in zebrafish and mouse early
postnatal ducts and induced β-cell-specific genes in human adult duct-derived organoids. We also defined genomic
sites that are bound and repressed by REST in the embryonic pancreas. Our findings show that REST-dependent
inhibition ensures a balanced production of endocrine cells from embryonic pancreatic progenitors.
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Progress in our understanding of the transcriptional
mechanisms underlying pancreatic β-cell differentiation
has been crucial for recent advances in the development
of regenerative therapy strategies for type 1 diabetes mel-
litus, including efforts to generate functional β cells from
stem cells, organoids, or in vivo reprograming (Rezania
et al. 2014; Huch and Koo 2015; Zhou and Melton 2018).
Pancreatic islet cell transcription is also central to the
mechanisms that underlie various forms of diabetes (Ser-
vitja and Ferrer 2004; Guo et al. 2013; Miguel-Escalada
et al. 2019).
Cellular programming and differentiation result from
an interplay of positive and negative transcriptional regu-
latorymechanisms (Crews and Pearson 2009; Graf and En-
ver 2009). Several DNA binding transcription factors are
known to promote endocrine differentiation during pan-
creas development (Sussel et al. 1998; Gradwohl et al.
2000; Osipovich et al. 2014; De Vas et al. 2015). A more
limited number of transcriptional regulators, such as
HES1 and TEAD-YAP, have been shown to exert negative
endocrine regulation (Jensen et al. 2000; Cebola et al.
2015; Mamidi et al. 2018). Some lines of evidence have
also suggested that the RE-1 silencing transcription factor
(REST; also known as NRSF, for neural-restrictive
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silencing factor) could be a negative regulator of endocrine
differentiation during pancreas development (van Are-
nsbergen et al. 2010).
REST is best known for its role as a suppressor of neuro-
nal genes in nonneuronal cell types (Schoenherr and An-
derson 1995). It binds a 21-bp DNA recognition sequence
and has two repressor domains that recruit corepressor
complexes. Consistent with its function to inhibit neuro-
nal genes, REST is largely expressed in nonneuronal cell
types. However, REST is not expressed in endocrine cell
lines, and several genes that are repressed by REST are ac-
tive in islet cells (Atouf et al. 1997; Martin et al. 2008,
2012). Furthermore, genome-wide studies in embryonic
stem cells and nonneuronal cell types have shown direct
binding of REST near β-cell-enriched genes (Johnson
et al. 2008; van Arensbergen et al. 2010; Mukherjee et al.
2016). REST binding sites in embryonic stem cells overlap
with genomic regions that carry Polycomb-repressed chro-
matin inFACS-purifiedmultipotent progenitors of theear-
ly embryonic pancreas (vanArensbergen et al. 2010).Many
of these Polycomb-repressed regions are β-cell regulatory
genes that are subsequently derepressed during pancreatic
endocrine differentiation, in parallel with the concomi-
tant loss of REST expression (van Arensbergen et al.
2010). These correlations suggested that REST could be
an important negative regulator of the endocrine differen-
tiationprogramof thedevelopingpancreas.A recent report
exploited this notion by inhibiting REST to enhance
PDX1-mediated activation of endocrine genes in adult
pancreatic exocrine cells (Elhanani et al. 2020).
Genetic loss-of-function studies, however, failed to
support a significant role of REST in pancreatic endocrine
differentiation.Cre/LoxP-based excision ofRest in pancre-
atic progenitors led to changes in the expression of some
endocrine genes but did not affect thenumberof endocrine
cells, suggesting itwas not an essentialmodulator of endo-
crine differentiation (Martin et al. 2015). Another pancreas
deletion study reported that REST tempers pancreatic tis-
sue damage and prevents acinoductal metaplasia, but the
study did not explicitly assess endocrine differentiation
(Bray et al. 2020). These studies, however, used an allele
that removes Rest exon 2 (Gao et al. 2011). Recent work
using a gene trap that disrupts transcription from all Rest
promoters revealed dramatic effects on embryonic neuro-
genesis that were not observed when targeting Rest exon
2 (Nechiporuket al. 2016). The same study showed that ex-
cision of Rest exon 2 does not prevent translation of a C-
terminal REST peptide that is able to bind DNA, recruit
corepressors, and repress target genes (Nechiporuk et al.
2016). Existing data, therefore, warrant a need to explore
the true impact of REST in pancreatic endocrine differen-
tiation using alternative genetic tools.
We have now inactivatedRest in the embryonic pancre-
as using a conditional allele that led to a marked increase
in endocrine differentiation, proliferation, and cell mass.
Inactivation of Rest in adult mature duct cells, however,
failed to elicit this effect. We used chemical inhibitors
to show that REST function is conserved in zebrafish
and represses endocrine genes in human pancreas organo-
ids. Finally, we defined key properties of the REST-depen-
dent program during pancreas organogenesis. Our results,
therefore, show an essential role of REST as a major nega-
tive regulator of pancreatic endocrine differentiation.
Results
REST expression in pancreas is largely restricted
to progenitors and duct cells
The expression of REST in pancreatic cell types has been
difficult to resolve unequivocally owing to low expression
levels and lack of robust antibodies (vanArensbergen et al.
2010; Martin et al. 2015). We found nuclear REST immu-
noreactivity in most nonendocrine epithelial and mesen-
chymal cells of the mouse E12.5 pancreas, whereas from
E14.5 onward it was largely restricted to duct-like clus-
ters, and absent from acinar and endocrine cell clusters
(Supplemental Fig. S1A). Purified duct cells from adult
and E18.5 Sox9-eGFP transgenic mice (Gong et al. 2003)
confirmed Rest mRNA expression in duct cells (Supple-
mental Fig. S1B,C). Finally, single-cell RNA-seq data (Ta-
bula Muris et al. 2018) showed Rest mRNA in adult duct
and nonepithelial cells but not in acinar or endocrine cells
(Supplemental Fig. S1D). These results reinforce the no-
tion thatREST is expressed in embryonic bipotent progen-
itors and adult pancreatic ductal cells but is not detected
in endocrine cells, consistent with a potential function
of REST as a negative regulator of pancreatic endocrine
differentiation.
REST inactivation in pancreatic progenitors induces
Neurog3
Previous genetic studies concluded that genetic ablation
of Rest in pancreatic multipotent progenitors has no im-
pact on the formation of NEUROG3+ endocrine precur-
sors or hormone-producing cells (Martin et al. 2015),
although this was examined in a mouse model that cre-
ates a deletion ofRest exon 2, which produces a functional
isoform that can still bind DNA and recruit corepressors
(Nechiporuk et al. 2016). We thus used an allele that en-
ables conditional excision of exon 4, which encodes
>75% of REST protein residues (Yamada et al. 2010).
Breeding this line with a Pdx1-Cre transgene (Gu et al.
2002) enabled the excision of Rest and a severe depletion
of REST protein in most embryonic pancreatic epithelial
cells (hereafter referred to asRestpKOmice) (Supplemental
Fig. S2A–C).
Previous work showed that REST binds to pancreatic
endocrine regulatory genes inmouse ES cells and that dur-
ing embryonic pancreas differentiation, REST target genes
loose Polycomb-repressed chromatin and undergo tran-
scriptional activation (van Arensbergen et al. 2010). To
directly test whether this means that REST truly acts as
a repressor of endocrine differentiation during pancreas
development, we examined expression of the endocrine
lineage-determinant NEUROG3 in RestpKO embryos.
This showed a 3.0-fold ± 0.03-fold increase of Neurog3
mRNA in pancreas fromRestpKO versus control E13.5 em-
bryos (SEM, Student’s t-test P < 0.01) and 1.7-fold
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increased NEUROG3 protein (P< 0.05) (Fig. 1A,B). At
E18.5, a time point inwhich thewave ofNEUROG3+ cells
have normally begun to wane, Neurog3 mRNA was
10.7-fold ± 1.2-fold higher in RestpKO embryos (P < 0.01)
(Fig. 1A). Furthermore, E18.5 mutant pancreas showed
an approximately sixfold increase in NEUROG3+ cells
normalized by the total number of CK19+ cells (P< 0.01)
(Fig. 1C). Several NEUROG3+ cells in mutant pancreas
appeared to line the epithelium of large ducts (Fig. 1C).
Therefore, REST inactivation in pancreatic progenitors
led to an increased yield of NEUROG3+ cells throughout
embryogenesis.
During normal pancreas development, the activation of
Neurog3 is followed by cell cycle exit of most progenitor
cells (Miyatsuka et al. 2011; Krentz et al. 2017). This chan-
ge in cell cycle activity has been shown to occur in dis-
crete, strongly expressing NEUROG3+ cells, in contrast
to remaining bipotent progenitor cells, which also express
Neurog3 mRNA but very low, often undetectable NEU-
ROG3 protein (Villasenor et al. 2008). We therefore inves-
tigated if REST inactivation affected the proliferation of
discrete NEUROG3-expressing cells. Immunofluores-
cence analysis of E18.5 RestpKO pancreas showed that
48.3%±6.8% of NEUROG3+ cells coexpressed Ki67 ver-
sus 4.6%±1.5% in control embryos (P< 0.01) (Fig. 1D).
This suggests that REST acts as a negative regulator of
cell cycle exit in NEUROG3+ cells, which could contrib-
ute in part to the increased number ofNEUROG3+ cells in
RestpKO embryonic pancreas.
During embryogenesis, NEUROG3+ cells arise from
pancreatic progenitors that form a tubular plexus that pro-
gressively evolves into a ductal tree (Gu et al. 2002; Solar
et al. 2009; Bankaitis et al. 2015). We tested whether Rest
deficiency could not only increase the yield of NEUROG3
+ cells during embryonic development but also cause per-
sistent Neurog3 activation in the duct epithelium
throughout postnatal life. We therefore examined postna-
















































































































































Figure 1. Rest inactivation in pancreatic
progenitors induces NEUROG3. (A) Neurog3
mRNA increases in E13 and E18RestpKO pan-
creas. Normalization by Hprt mRNA; n=3–4
mice per group. (B) Western blot and quantifi-
cations of NEUROG3 in nuclear extracts
from E13.5 control and RestpKO pancreas.
LamininB1 was used as loading control. n=2
samples per group with a pull of three E13.5
pancreas per sample. (C ) Immunofluores-
cence for NEUROG3 (red), cytokeratin 19
(CK19; green), and DAPI (blue) in E18.5 con-
trol and RestpKO pancreas. Arrowheads indi-
cate NEUROG3+ cells. Bars show
NEUROG3+ CK19+ cells in E18.5 pancreas.
Scale bar, 100 µm. (D) Immunofluorescence
for NEUROG3 (red), Ki67 (green), and DAPI
(gray) in E18.5 pancreas. Empty arrowheads
indicate NEUROG3+Ki67− cells, and white
arrowheads indicate NEUROG3+Ki67+ cells.
n=4–6 mice per group. Scale bar, 50 µm. (E)
Representative whole mounts for NEU-
ROG3+ (red), DBA (green), and insulin (blue)
of the tail of E18.5 control and RestpKO pan-
creas. Scale bars, 100 µm. Error bars are
SEM. (∗) P≤ 0.05, (∗∗) P≤0.01.
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NEUROG3+ cells (Supplemental Fig. S3). This suggests
that additional REST-independent mechanisms are re-
quired for persistent Neurog3 activation during postnatal
life.
Our studies, therefore, show that REST tempers the
yield of NEUROG3+ cells in the embryonic pancreas, in
part by suppressing NEUROG3+ cell proliferation. The
lack of NEUROG3+ cells in the adult RestpKO pancreas
suggests that REST function is not required to prevent
the continuous formation of endocrine progenitor cells
from duct cells during postnatal life.
Increased β-cell mass in mice lacking REST in pancreatic
progenitors
Given that the inactivation of REST in pancreatic progen-
itors led to the expansion of endocrine-committed NEU-
ROG3+ progenitors, we investigated how this influenced
the formation of endocrine cells. Whole-mount stainings
for NEUROG3, CK19, and insulin in E18.5 pancreas not
only confirmed increased NEUROG3+ cells but also
showed a marked increase of the number of insulin-ex-
pressing cells (Fig. 1E).
Because the increase in NEUROG3+ cells observed in
RestpKO pancreas was transient, we investigated whether
increased β-cell mass was maintained in the adult pancre-
as. Young (12- to 16-wk-old) male RestpKO mice had nor-
mal weight (24.39 g ± 0.5 vs. 24.36 g ± 0.6 control mice)
and fasting glycemia (49.71 mg/dL±1.83 vs. 54.26 mg/
dL±3.44 control mice). Morphometric analysis, however,
showed an approximately twofold increase of β-cell mass
in 12-wk-old RestpKO versus control mice, which was pri-
marily owing to an increase of large islets (Student’s t-test,
P< 0.01), as well as an apparent increase in glucagon-ex-
pressing cells (Fig. 2A–D). These findings, therefore,
showed that inactivation ofRest in pancreatic progenitors
results in a transient expansion of NEUROG3+ cells and a
sustained increase of pancreatic endocrine cell mass.
REST is a direct regulator of pancreatic endocrine
differentiation
Several genome-wide studies show that REST binds and
regulates different genes in different cell types (Bruce
et al. 2009; Hwang and Zukin 2018), although REST bind-
ing sites have not yet been mapped in pancreas. To study
how REST controls pancreatic endocrine differentiation,
we identified REST genomic binding sites and REST-de-
pendent transcriptional changes in embryonic pancreatic
progenitors. We performed ChIP-seq analysis using a
monoclonal antibody (12C11) directed to the REST C-ter-
minal region (Chen et al. 1998), and used chromatin from
E13.5 wild-type pancreas, a stage at which REST expres-
sion is largely confined to progenitor cells and inter-
spersed mesenchymal cells (Supplemental Fig. S1A). We
detected 1968 REST-bound regions (Supplemental Table
S1). These were highly enriched in canonical REST recog-
nition motifs, confirming the specificity of REST binding
(Supplemental Table S2; Fig. 3A).
The binding properties of repressors are poorly under-
stood. IntegrationwithATAC-seq profiles fromE13.5 pan-
creas revealed that REST-bound regions were accessible
to transposase cleavage yet had an accessibility footprint
thatwas narrower than recognition sites of activating pan-
creatic transcription factors, plausibly because active reg-
ulatory elements are occupied by multiple DNA binding
factors (Supplemental Fig. S4).
DNA binding transcription factors that are expressed in
multiple cell types often bind to different genomic regions
across cell types (e.g., see Servitja et al. 2009), and this has
also been observed for REST (Bruce et al. 2009; Hwang and
Zukin 2018). We found that 1806 (∼94%) of REST-bound
sites in embryonic pancreas were shared with embryonic
stem cells but only 1030 (∼53%) with neuronal stem cells
(Johnson et al. 2008; Whyte et al. 2012), whereas 91
(∼4.7%) were exclusively detected in mouse embryonic
pancreas (Fig. 3B).
These findings, therefore, defined direct REST-bound
regions in early embryonic pancreas. They confirmed
that numerous bound regions vary across cell types, al-
though the vast majority are shared with embryonic
stem cells (Supplemental Table S3).
To further assess REST function in pancreatic pro-
genitors, we compared RNA-seq profiles of E18.5 RestpKO
versus control pancreas, a stage at which many progeni-
tors have already been allocated to distinct cellular lineag-
es. We identified 484 down-regulated and 259 up-
regulated genes in RestpKO E18.5 embryonic pancreas (ad-
justed P< 0.05) (Supplemental Table S4). We found that
29.8% of up-regulated genes were bound by REST (Fisher
P< 10−4, relative to 15,548 expressed genes), whereas only
9.8% of down-regulated genes were bound, a similar fre-
quency as all expressed genes (11.2%; Fisher P = 0.81)
(Fig. 3C; Supplemental Table S5). This was consistent
with the notion that the RestpKO phenotype reflects a
transcriptional repressor function of REST in the develop-
ing pancreas.
REST binds to distal and proximal genomic sites, both
ofwhich are likely to harbor functional relevance. Howev-
er, up-regulated genes in RestpKO were most strongly en-
riched among genes with promoter-proximal REST
binding (Fisher P< 104) (Fig. 3D), which was also observed
in early experiments that examined dominant negative in-
hibition of REST in mouse ESCs (Johnson et al. 2008) Fur-
thermore, REST-bound up-regulated genes were enriched
in Polycomb-repressed chromatin in pancreatic progeni-
tors (odds ratio = 3.61, Fisher P= 7 × 10−4 for up-regulated
REST-bound genes; odds ratio = 1.12, P= 0.75 for down-
regulated REST-bound genes; both calculated relative to
H3K27me3-enriched genes in PDX1+ E10.5 pancreatic
progenitors as defined by van Arensbergen et al. 2010)
(Fig. 3E).
Consistent with the increase in endocrine cells in
RestpKO pancreas, genes that were up-regulated, as well
as pancreas REST-bound genes at large, showed a strong
enrichment in pancreatic endocrine annotations, includ-
ing insulin secretion and processing, glucose homeosta-
sis, and endocrine pancreas development (Fig. 3F,G;
Supplemental Tables S6, S7). Closer inspection of
Rovira et al.
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individual loci disclosed the location of REST-bound re-
gions at important regulators of pancreatic differentiation
(Neurog3,Neurod1, Insm1,Hnf4a,Onecut1, Pax4,Glis3,
and Hnf1a), insulin biosynthesis or exocytosis (Pcsk1,
Pcsk2, Scg3, Snap25, and Syt7), as well as endocrine cell
growth (Bid, Mapk8IP1, Mapk10, and Mapk11) (Fig. 3H;
Supplemental Table S3). Regions bound by REST in em-
bryonic pancreas but not in neural or even embryonic
stem cells included genes previously associated with pan-
creatic differentiation and function such as Isl1 (Ahlgren
et al. 1997), Prox1 (Paul et al. 2016), orCdh13 (Supplemen-
tal Fig. S5; Tyrberg et al. 2011). Given the increased prolif-
eration ofNEUROG3+ cells, it was also interesting to note
up-regulation of REST-bound positive cell cycle regulators
in RestpKO, including Cdk5r2, Cdk2ap1, Ccnd1, Mapk3,
and Ret (Supplemental Fig. S5; Supplemental Table S5).
These studies, therefore, identified direct target genes
throughwhich REST controls pancreatic endocrine differ-
entiation programs.
Postnatal inactivation of REST
Embryonic duct-like bipotent progenitors express many
duct cell markers, as well as progressively lose their pro-
genitor capacity as theymature to differentiated duct cells
(Solar et al. 2009; Kopinke et al. 2011; Kopp et al. 2011;
Bankaitis et al. 2015) REST expression, however, is main-
tained as embryonic progenitors transition to adult differ-
entiated ductal cells (Supplemental Fig. S1). We therefore
asked whether REST inactivation immediately after birth
could increase the capacity for de novo generation of endo-
crine cells. To this end,we used theHnf1b-CreERT2trans-
genic line (Solar et al. 2009) to excise theRestLoxPallele in





Figure 2. Increased β-cell mass inRestpKOmice. (A) Representative images of 10 × 10 frame reconstructions used for β-cell morphometry
of insulin (red) and DAPI (green) stainings in pancreas from 12-wk-old control and RestpKO mice. Scale bar, 2 mm. (B) Morphometry of β-
cell mass estimated from insulin surface area/total DAPI surface area (percentage). RestpKO mice have an approximately twofold increase
in β-cell mass. n =12 sections from five to six mice in each group. (C ) Islet size in control and RestpKO adult pancreas. (D) Representative
immunofluorescence for glucagon (red), insulin (green), and DAPI (blue) in whole-pancreas from 12-wk-old control and RestpKO pancreas.
Scale bar, 200 µm. Error bars indicate SEM. (∗∗) P≤0.01.
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Figure 3. Functional direct REST targets in the embryonic pancreas. (A) Top de novo and known motif enrichments in REST-bound re-
gions. (B) REST-bound regions in E13.5 pancreas,mESCs, andmNSCs. (C ) Percentage of up-regulated and down-regulated genes inRestpKO
mice, or all genes, thatwereboundbyREST.Results indicate thatRESTpredominantly acts as a repressor.P-values areFisher exact test. (D)
RESTbindspreferentially to promoter-proximal (0- to 5-kb) regions of genes thatwereup-regulated inRestpKOmice. (E) Percentageof differ-
entially expressed genes thatwere bound by REST, broken down byH3K27me3 enrichment in purified pancreatic progenitors in (vanAre-
nsbergen et al. 2010). REST binding was enriched in genes that were up-regulated in RestpKO and showed H3K27me3 in progenitors. P-
values from Fisher exact test. (F ) Up-regulated genes were functionally annotated using Gorilla (Eden et al. 2009), and REVIGO (Supek
et al. 2011)was used to visualize annotation clusters. Themost significant terms are highlighted according to a P-value color scale. (G) Sig-
nificant GSEA terms for up-regulated genes. (H) REST binding associated to pancreatic endocrine development (Neurog3 and NeuroD1),
insulin secretion (Snap25 and Pcsk2), and β-cell survival (Mapk11 and Mapk8ip2) genes in E13.5 pancreas. Y-axes are −log10 P-values.
The vert. cons. track depicts vertebrate conservation.
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a Rosa26-LSL-RFP reporter (Luche et al. 2007) to trace
the progeny of cells that have undergone Rest excision
(Fig. 4A). We treated dams of triple transgenic newborns
(hereafter called RestdKO Rosa26RFP) or Hnf1b-CreERT2;
Rosa26RFPcontrols with tamoxifen at postnatal days 1
and 3 and then analyzed mice after weaning (Fig. 4B).
This showed that the number of insulin+/RFP+ and gluca-
gon+/RFP+ cells was increased 5.3-fold ± 0.5-fold and 6.4-
fold ± 1.6-fold (Student’s t-test P < 0.01), respectively, in
RestdKO mice relative to Hnf1b-CreERT2;Rosa26RFP con-
trol mice (Fig. 4C). These results indicate that although
the inactivation of REST in embryonic pancreatic progen-
itors did not result in persistent activation of endocrine
progenitor markers throughout adult life, induced inacti-
vation of REST in neonatal pancreas did transiently in-
crease endocrine cell formation.
In contrast, REST inactivation in pancreatic duct
cells from 12 wk olds using the same lineage tracing
model did not lead to significantly increased number of in-
sulin+/RFP+ cells 4 wk after induction (2.54%±0.33% in
RestdKORosa26RFP vs. 1.96%±0.49%incontrolmice; Stu-
dent’s t-test, P= 0.177) (Supplemental Fig. S6). Thus, al-
though REST retains an essential function to suppress
endocrine cell formation in early postnatal periods, this
role subsides in adultmice, consistentwith amore limited
differentiation potency of mature duct cells.
Chemical inhibition of REST in zebrafish
Encouraged by the observation that inactivation of REST
in early postnatal duct cells increased the de novo genera-
tion of endocrine cells, we explored whether similar
A B
C
Figure 4. Pancreas-specific inactivation of
Rest in neonatal ducts. (A) Schematic of ge-
neticmodels used to inactivateRest and ac-
tivate RFP expression in duct cells and
progeny. Hnf1b-CreERT2 is a BAC trans-
genic that specifically marks duct cells
(Solar et al. 2009), as well as non-Rest-ex-
pressing ∂ cells in reporters that are excised
with high efficiency (Rovira et al. 2021), but
not other endocrine or acinar cells. (B) Sche-
matic of the lineage tracing experiment. Ta-
moxifen was given to mothers at day 1 (P1)
and day 3 (P3) after delivery, and mice
were analyzed at P30. Hnf1b-CreERT2;
Rosa26RFP control mice were also treated.
(C ) Representative images of double-posi-
tive RFP (red) and insulin (green) cells and
of double-positive RFP (red) and glucagon
(green) cells in RestdKO and control mice.
The graph shows RFP-expressing glucagon
and insulin cells in RestdKO versus control
mice. n =5–6 mice per each group. Arrow-
heads indicate double-positive cells, and
an asterisk marks examples of cells in a
duct, which were very efficiently labelled.
Scale bar, 100 µm. Error bars are SEM. Stu-
dent’s t-test; (∗∗) P<0.01.
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effects could be extended to other model systems using
chemical inhibition of REST. We used X5050, recently
identified in a high-throughput screen to inhibit REST
by protein destabilization (Charbord et al. 2013).
To study REST function in zebrafish, we used a double
transgenic line in which glucagon- and insulin-expressing
cells show green and red fluorescence, respectively (Ins:
mcherry/Gcga:gfp). We treated zebrafish embryos at 3
dpf with X5050 for 3 d or with the Notch inhibitor
DAPT as a positive control (Parsons et al. 2009), and at 6
dpf, we dissected the pancreas to quantify secondary islet
formation as a readout for endocrine cell differentiation.
Secondary islets are normally apparent in∼10%of control
larvae at 5 dpf, and this percentage increases gradually
thereafter (Parsons et al. 2009). Compared with DMSO
controls, X5050-treated 6-dpf embryos displayed a dose-
dependent increase in secondary islet formation (5 µM
and 50 µM: 2.2-fold ± 0.4-fold and 3.5-fold ± 0.1-fold in-
crease; SD, Student’s t-test P < 0.05 and P < 0.01, respec-
tively), which was comparable with 50 µM DAPT (4.2-
fold ± 0.4-fold, P< 0.01) (Fig. 5A). These results suggest
that REST regulation of pancreatic endocrine differentia-
tion is conserved in zebrafish and that this process can
be manipulated through chemical inhibition.
A
B
Figure 5. REST regulation of endocrine dif-
ferentiation is conserved in zebrafish. (A)
Embryos of Ins:mCherry/Gcga:GFP double-
transgenic zebrafish line treated with 50
µM DAPT (Notch inhibitor used as positive
control), 0.5 or 5 µM X5050, or vehicle
(DMSO, negative control) from 3 dpf until 6
dpf. After drug treatment at 6 dpf, zebrafish
pancreas was dissected, and the presence or
absence of secondary islets was quantified.
Arrows show representative secondary islets
of double-transgenic zebrafish embryos (Ins:
mCherry/Gcga:GFP; [blue] DAPI). The graph
shows the percentage of zebrafish with
detectable secondary islets in each condi-
tion. n=20–25 fish per each condition. (B)
An Ins:NTR-mCherry line was used to selec-
tively ablate β cells upon treatment with 5
µM nifurpirinol (NFP) (Pisharath et al.
2007; Bergemann et al. 2018) in 3-dpf embry-
os; 24 h later after complete β-cell ablation of
the principal islet, embryos were exposed to
5 µM ×5050 or vehicle, and β cells were ana-
lyzed 36 h later. Representative images of β-
cell regeneration in Ins:NTR-mCherry em-
bryos treated with vehicle (DMSO), with
NFP only, or with NFP and X5050. (Red) In-
sulin, (blue) DAPI. The graph shows the per-
centage of pancreas showing >10 insulin-
expressing cells in every condition. n=32–
36 fish per each condition. Scale bars, 200
µm. Error bars are SEM. (∗∗) P< 0.01, (∗) P<
0.05, χ2 test.
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We next investigated whether REST inhibition could ac-
celerate β-cell neogenesis after β ablation with nifurpirinol
(NFP), using Ins:NTR-mcherry transgenic zebrafish (Berge-
mann et al. 2018). In this model, 3-dpf embryos are treated
with NFP, causing ablation of >95% of β cells in 24 h and
full recovery of β-cell mass in 48–72 h (Bergemann et al.
2018). We note that at 3 dpf, all β cells form part of principal
islets. After washing NFP, we ascertained complete β-cell
ablation with a stereomicroscope and then treated embryos
with X5050 or vehicle, and 36 h later, we examined which
embryos had recovered >10 β cells, a threshold that enables
unequivocal distinction from complete ablation. We ob-
served that 73.4%±3.3%ofX5050-treated embryos showed
>10 insulin-positive cells in the principal islet, whereas this
was only seen in 34.7%±6.1% of controls (mean and SD of
34–38embryos ineachgroup, χ2 test,P<0.01) (Fig. 5B).Thus,
REST inhibition promoted β-cell formation in a zebrafish
embryo regeneration model.
REST inhibition in human organoids
Wenext explored the impact of RESTmanipulation in hu-
man cells. We first validated that 24-h treatment of an im-
mortalized duct cell line (PANC-1) with X5050 caused an
∼50% reduction of REST full-length protein, as well as a
relative increase in the REST4 isoform, as previously de-
scribed (Fig. 6A; Charbord et al. 2013). Next, we studied
ex vivo organoid cultures fromhuman adult ducts isolated
from the exocrine fraction of the pancreas of cadaveric do-
nors. Organoids were generated and expanded as previous-
ly described (Boj et al. 2015), and experiments were
performed at passages 3–4 (Fig. 6B). Currently, the efficien-
cyof endocrine differentiation frompublished ex vivo pan-
creas organoid protocols is still limited (Huch et al. 2013;
Boj et al. 2015; Loomans et al. 2018). We thus investigated
if REST inhibition in pancreatic human organoids could
promote the activation of pancreatic endocrine lineage
genes. We treated human organoids with X5050 for 48 h
and observed only rare endocrine cells in treated and non-
treated organoids. However, X5050-treated organoids
showed induction of INS, NEUROG3, and PDX1 mRNA
levels (2.27-fold ± 0.43-fold, 3.18-fold ± 1.06-fold, and
2.18-fold ± 0.54-fold increased vs. DMSO, respectively;
SD, Student’s t-test,P< 0.01),whereas theduct cellmarker
SOX9mRNAdid not change (Fig. 6B). These results there-
fore show that chemical interference of REST in adult hu-
man pancreas organoids did not lead to β-cell formation,
consistent with genetic findings in adult mice, although
it induced the transcription of endocrine genes.
Discussion
Despite early suggestions that REST could be important
for pancreatic endocrine differentiation during embryonic
A
B
Figure 6. REST chemical inhibition in hu-
man pancreatic organoids. (A) Western blot
analysis of REST FL (full-length) and
REST4 protein levels in PANC1 cells treated
with X5050 50 µM or DMSO (control).
(Lamin B1) Loading control. Bar plot shows
the quantification of the Western blot for
REST. (B) Human organoids generated from
pancreatic exocrine fractions from two ca-
daveric donors were treated at passage 3 for
48 h with 5 µM X5050 or DMSO (control ve-
hicle). qPCR analysis of mRNA for indicated
genes, relative to TBP. Scale bars, 200 µm. Er-
ror bars are SD. Student’s t-test, (∗∗) P <0.01.
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development (Martin et al. 2008, 2012; van Arensbergen
et al. 2010), conditional ablation ofRest in themouse pan-
creas unexpectedly showedmodest gene expression differ-
ences and no quantitative changes in endocrine cell
formation (Martin et al. 2015). This result clearly did
not suggest a major regulatory role in pancreas endocrino-
genesis. We have now combined genetic and chemical
perturbations to show that REST plays a key evolutionary
conserved role to modulate the generation of endocrine
cells during pancreas organogenesis.Wedefine for the first
time a blueprint of direct REST target genes in the embry-
onic pancreas that underpin this regulatory function. We
further show that the capacity to increase endocrinogene-
sis upon REST inactivation in duct cells decreases during
postnatal life, whereas REST inhibition in human adult
pancreas organoids influenced expression of endocrine
genes but did not trigger endocrine cell formation.
These findings therefore establish REST as an important
regulator of endocrinogenesis during embryonic pancreas
development.
During pancreas development, a subset of HNF1B+
duct–endocrine bipotent progenitors that form a tubular
plexus trigger an endocrine gene program, whereas others
give rise tomature ductal cells (Solar et al. 2009; Bankaitis
et al. 2015). Themechanisms that underlie this binary lin-
eage choice in a seemingly uniform pool of progenitors is
unclear. Our results suggest that REST restrains the fre-
quency with which bipotent progenitors consolidate an
endocrine vs. duct fate. On the other hand, the fact that
REST deficiency did not cause an en masse conversion
of bipotent progenitors into endocrine cells is consistent
with the notion that REST is not the sole guardian of en-
docrine differentiation but instead acts in concert with
other positive and negative regulators to define a differen-
tiation probability.
Genetic experiments have indeed revealed numerous
transcriptional regulators that promote pancreatic endo-
crine cell formation, including NKX6-1, NKX2-2, NEU-
ROG3, HNF1B, and INMS1, among others (Sussel et al.
1998; Gradwohl et al. 2000; Osipovich et al. 2014; De
Vas et al. 2015). Among DNA binding factors that sup-
press endocrinogenesis, Hippo-responsive TEAD-YAP
complexes are an integral component of pancreatic multi-
potent progenitor enhancers and plausibly counteract en-
docrine differentiation by promoting a progenitor
transcriptional state (Cebola et al. 2015; Mamidi et al.
2018; Rosado-Olivieri et al. 2019). Notch-responsive tran-
scriptional repressors, notably HES1, bind near endocrine
genes, where they are likely to exert direct transcriptional
repression (Jensen et al. 2000; de Lichtenberg et al. 2018).
An important unsolved question is how REST interplays
with such inhibitory and positive regulators at different
stages to ensure a timely and balanced generation of endo-
crine cells.
The inhibitory function of REST has potential implica-
tions for efforts to enhance endocrinogenesis in various in
vivo or in vitro settings. Current pancreas organoid mod-
els are limited because existing protocols largely recapitu-
late exocrine cell expansion. On the other hand, our
experiments showed that REST derepression enhanced
endocrinogenesis in embryonic progenitors and even early
postnatal pancreas but was clearly less efficient in the
adult differentiated pancreas. This may mean that REST
restrains endocrine differentiation in progenitors that ex-
press positive endocrine regulators and have the appropri-
ate epigenetic competence, whereas mature duct
epithelial cells may lack these properties. Nonetheless,
the observation that REST inhibition did elicit increased
expression of islet endocrine genes in human exocrine
organoids, together with the recent observation that it
can enhance transcription factor-mediated reprogram-
ming of mouse adult exocrine cells (Elhanani et al.
2020), suggests that REST modulators may form part of
an arsenal for futuremanipulations to promote endocrino-




All experiments were approved by the Institutional Animal Care
Committee of theUniversity of Barcelona.MicewithRest exon 4
floxed allele (RestLSL) (Yamada et al. 2010) were crossed to Pdx1-
Cre (Gu et al. 2002) or Hnf1b-CreERT2 (Solar et al. 2009) and
Rosa26-LSL-RFP transgenic lines (Luche et al. 2007).We also gen-
eratedRestLSL mice carrying a different Pdx1-Cre transgene (Hin-
gorani et al. 2003) and confirmed increased endocrine cellmass in
adult mice as well as increased NEUROG3+ cells at E18.5. To in-
duce recombination in triple transgenics (Hnf1b-CreERT2;
Rosa26RFP;RestLSL or Hnf1b-CreERT2;Rosa26RFP control
mice), 20mg of tamoxifen (SigmaT5648) was administered by ga-
vage to the mother at days 1 and 3 after delivery. Mice were then
sacrificed at 30 d of age. For adults, tamoxifenwas given by gavage
in three doses (20mg, 20mg, and 10mg) over 1 wk to 8- to 12-wk-
old mice, and mice were analyzed 4 wk later. Oligonucleotides
used for genotyping are in Supplemental Table S8.
Dissociation and FACS analysis of pancreatic cells
Adult and E18.5 mouse pancreas from Sox9-eGFP transgenics
(Gong et al. 2003) were digested in 1.4 mg/mL collagenase-P
(Roche) for 20–30min at 37°C. Peripheral acinar-ductal units, de-
pleted of endocrine islets, were prepared as previously described
(Wang et al. 2013). Tissue was filtered through 600-μm and 100-
μm polypropylene meshes (BD), and peripheral acinar-ductal
units were further dissociated in diluted TrypLE (Invitrogen) for
5min at 37°C.Dispersed cells were filtered through a 40-μmpoly-
propylene mesh (BD) before FACS sorting.
Immunoblots
Nuclear extracts were prepared as previously described (Maestro
et al. 2003) and separated on a 7% SDS-PAGE gel and transferred
to an Immobilon polyvinylidene difluoride membrane (Milli-
pore). Immunodetection was performed with mouse 12C11
anti-REST (1:1000) or rabbit anti-LaminB1 (1:2000; Cell Signal-
ing). Quantification was performed with ImageJ-Fiji.
RNA analysis
RNA was isolated using the RNeasy minikit (Qiagen) or TRIzol
followed by DNase I treatment (Invitrogen). RNA was reverse-
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transcribed with SuperScript III reverse transcriptase (Roche) and
random hexamers, and qPCR was performed on a 7900 real-time
PCR system (Applied Biosystems) using Power SYBR green (Ap-
plied Biosystems). Oligonucleotides are shown in Supplemental
Table S8.
RNA-seq
DNase-treated RNA (RIN>8) was generated from three E18.5
pancreas for each genotype and used for 100-bp paired-end read
Illumina sequencing. Readswere aligned to theNCBI36/mm9 ge-
nome using STAR (v2.3.0) (Dobin et al. 2013) with default param-
eters, allowing only uniquely mapped reads. The resulting bam
files were used to quantify gene expression using FeatureCounts
(v1.5) using UCSC mm9 reference gene annotations. Differential
expression analysis was performed using DESeq2 (Love et al.
2014) using an adjusted P-value < 0.05 cutoff.
ChIP-seq
ChIPs were from dissected E13.5 pancreatic buds and were per-
formed as described by van Arensbergen et al. (2010, 2013).
ChIP DNA (1–2 ng) from two independent pools of E13.5 pan-
creas were used for ChIP sequencing of single-end 50-bp reads.
Reads were aligned to NCBI36/mm9 genome using Bowtie2
(v2.2.5) allowing for one mismatch. Bam files were filtered to re-
tain reads with aMAPQ≥ 10. Bam files from biological replicates
were pooled using samtools, and peaks were called usingMACS2
(v2.1.0) using default parameters. Input DNA was used to define
significant peaks at a false detection rate of <0.05.
Functional gene annotations
GSEA was performed in preranked lists and analyzed with 1000
permutations. Differentially expressed genes were functionally
annotated using Gorilla (Eden et al. 2009), and REVIGO (Supek
et al. 2011) was used to visualize most significant terms in each
GO cluster.
ATAC-seq profiles around transcription factor binding sites
To plot ATAC-seq profiles around transcription factor binding
sites (TFBSs), we conducted footprinting with HINT from the
RGT library (v0.13.1) (Li et al. 2019). An ATAC-seq model and
paired-end data were specified for tool execution, using aligned
read BAM files and ATAC-seq peaks in BED format. Once foot-
prints were called, overlapping TFBSs were found using the
RGT-matchingmotif tool and the complete JASPARmotifs data-
base. For REST (MA0138.2), we selected only footprints overlap-
ping a REST ChIP-seq peak using ChIPpeakAnno (v3.18.1),
GenomicRanges (v1.36.0), and Bioconductor (v3.9.0) R (v3.6.3)
and lifting to mm10. Normalized ATAC-seq profiles around
TFBSs of interest were generated with HINT for a 500-bpwindow
size, enabling ATAC-seq bias correction.
REST binding enrichment in differentially expressed genes
Genomic regions were associated with genes using GREAT v3.0,
applying default parameters to the basal plus extension associa-
tion rule (McLean et al. 2010). Proximal and distal REST-bound
regions were defined as <5 kb or >5 kb from the transcriptional
start sites, respectively. REST-bound genes were annotated based
on H3K27me3 enrichment (van Arensbergen et al. 2010).
Motif analysis
De novo and knownmotifs of REST-bound regions were analyzed
with HOMER, using a 500-bp window centered on the REST
peak.
Immunolocalization methods
Paraffin-embedded pancreas were processed for immunolocaliza-
tion as described by Maestro et al. (2003). Whole-mount staining
of E18.5 pancreas was performed as previously described (Ahn-
felt-Rønne et al. 2007) without TSA amplification. For β-cell
mass measurements in 3-mo-old mice, 4-µm sections were ob-
tained at 150-µm intervals, and 21–24 sections per pancreas
were analyzed by immunofluorescence for insulin and DAPI. Im-
ages were taken by automated capturing and reconstruction of 10
× 10 frames using a Leica SP confocal microscope. Insulin-posi-
tive and total tissue areas (measured byDAPI saturation) were de-
termined by ImageJ. Islet size distribution was quantified with an
automated ImageJ plugin. Antibodies are shown in Supplemental
Table S9.
Human organoid culture
Human exocrine tissue, obtained from the discarded fraction af-
ter human islet purifications from cadaveric organ donors
(Gmyr et al. 2000), was used only if islets were insufficient for
clinical transplantation and if scientific research was granted ac-
cording to national French regulations. Ethical approval for pro-
cessing pancreatic samples from deidentified organ donors was
granted by the Clinical Research Ethics Committee of Hospital
Clinic de Barcelona (HCB/2014/0926 and HCB/2014/1151).
Tissues wereminced and digested with 5mg/mL collagenase II
(Gibco) in human complete medium for 30 min to 1 h at 37°C.
The material was further digested with TrypLE (Gibco) for 5
min at 37°C, embedded in GFR Matrigel (Kerr Conte et al.
1996), and cultured in human organoid expansion medium (Boj
et al. 2015). After three passages, we treated organoids with
X5050 (Calbiochem) in human complete media for 48 h before
RNA analysis.
Zebrafish studies
Tg(gcga:GFP), Tg(T2KIns:hmgb1-mcherry), and Tg(ins:NTR-
mCherry) were obtained from Isabelle Mandfroid (University of
Liege, Belgium) (Parsons et al. 2009; Bergemann et al. 2018). Dou-
ble-transgenic Tg(gcga:GFP)/Tg(T2KIns:hmgb1-mCherry) em-
bryos were incubated from 3 dpf to 6 dpf at 28°C in the dark in
50 µM DAPT (Tocris) and 0.5 and 5 µM X5050 (Calbiochem)
(Charbord et al. 2013) or 1% DMSO in E3 (Parsons et al. 2009).
Zebrafish were then fixed overnight in 4% paraformaldehyde;
pancreas was dissected for confocal image analysis.
Tg(Ins:NTR-mCherry)was used for β-cell ablation studies upon
treatmentwith 5 µMnifurpirinol (NFP) (Bergemann et al. 2018) in
3-dpf embryos. In this model, 24 h after NFP treatment, >95% of
the β cells are ablated and β-cell mass recovered in 48–72 h (Par-
sons et al. 2009; Bergemann et al. 2018). NFP-treated embryos
were washed and treated with 5 µM X5050 or DMSO. β-Cell re-
generation was analyzed after 36 h. After drug treatment, 5-dpf
zebrafish were fixed overnight in 4% paraformaldehyde, and pan-
creas was dissected for confocal image analysis.
Tomicrodissect pancreas, fixed embryos were placed in PBS on
an agarose-lined plate. Then, using pulled capillaries as tools, first
the yolk and then thewhole foregutwere pried away from the em-
bryo. The pancreas was placed islet-down on a coverslip and dried
by removing all excess PBS. This coverslip was then mounted
REST inhibits pancreas endocrine differentiation
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onto a microscope slide. Water was introduced under the cover
slip to rehydrate the sample.
Confocal Z-series stacks were acquired on a Leica SP5 confocal
microscope. Maximum projections were obtained by LAS AF
software. To count endocrine cells, we used a double-transgenic
line. Tg(gcga:GFP) and Tg(T2KIns:hmgb1-mCherry), where glu-
cagon-positive cells were green and insulin-positive cells were
red. Upon maximum projections of Z-series of the entire pancre-
as, the presence or absence of secondary islets was computed.
Statistics
Statistical analyses were performed using either R or GraphPad
Prism 6. Statistical significance was calculated with a Fisher ex-
act test or an unpaired, two-tailed Student’s t-test with data ex-
pressed as mean±SEM unless otherwise specified. P-values <
0.05 were considered significant.
Data availability
ChIP-seq and RNA-seq data sets are available in GSE179120.
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